CytomX Therapeutics, Inc.
Matriptase and u-plasminogen activator substrates and other cleavable moieties and methods of use thereof

Last updated:

Abstract:

The invention relates generally to polypeptides that include a cleavable moiety that is a substrate for at least one protease selected from matriptase and u-plasminogen activator (uPA), to activatable antibodies and other larger molecules that include the cleavable moiety that is a substrate for at least one protease selected from matriptase and u-plasminogen activator, and to methods of making and using these polypeptides that include a cleavable moiety that is a substrate for at least one protease selected from matriptase and u-plasminogen activator in a variety of therapeutic, diagnostic and prophylactic indications.

Status:
Grant
Type:

Utility

Filling date:

15 Oct 2018

Issue date:

8 Jun 2021